Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : InvestRight Club Challenge -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Cullen who wrote (1805)	5/4/1999 2:18:00 PM
From: Jeffrey L. Henken	Respond to of 2662

As soon as I get home from work tonight I'll really go through it and look at ATIS too. Regards, Jeff

To: Bruce Cullen who wrote (1805)	5/4/1999 5:40:00 PM
From: Jeffrey L. Henken	Read Replies (1) \| Respond to of 2662

Reason's behind ORG's short selling may be due simply to the technical situation. Here is what I found at Market Edge's Second Opinion: Moving Average Convergence/Divergence (MACD) indicates a BEARISH TREND Chart pattern indicates a WEAK DOWNWARD TREND Relative Strength is BEARISH Up/Down volume pattern indicates that the stock is under DISTRIBUTION The 50 day MOVING AVERAGE is falling which is BEARISH The 200 day MOVING AVERAGE is falling which is BEARISH WATCH FOR RESISTANCE AT 11.78 Stochastics indicate stock is OVERSOLD RECOMMENDATION STOCK IS A SHORT SALE CANDIDATE; STOCK IS OVERSOLD; WAIT FOR RALLY TO SHORT STOCK, IF YOU ARE LONG; CLOSE POSITION OR MONITOR STOCK CLOSELY

To: Bruce Cullen who wrote (1805)	5/4/1999 6:12:00 PM
From: Jeffrey L. Henken	Read Replies (1) \| Respond to of 2662

Skin is considered an organ. Here's another reason why ORG is up against it with short sellers: Wedbush Morgan Securities issued a Company Report on December 31, 1998 for Organogenesis Inc.. biz.yahoo.com On December 31, 1998 Wedbush Morgan Securities's Research Department issued a 1 page Company Report on Organogenesis Inc. Report highlights: 'The fiscal 1998 and 1999 EPS estimates were reduced to ($0.45) and ($0.41), from ($0.25) and ($0.34) per share, respectively. The downward earnings revisions reflect lower- than-expected top-line and bottom-line 3Q98 results. A SELL rating was maintained with a price target of $4 3/4 per share.' Believe me Bruce, I have absolutely no faith in analyst's reports. Everyone seems to be negative on ORG, but how did they get the stock so high in the first place? They will change their tunes. Unfortunately for now the stock may drift back to 52 week lows if they don't change their tune soon. On ATIS the situation is really quite a bit better. Technically Market Edge says buy. Me I'm not so sure. quote.yahoo.com Thanks, Jeff